PAREXEL, a global biopharmaceutical services provider, has appointed three new vice presidents to its team. Robert Iser is the new VP of Regulatory Consulting Service, Dr. Bob Desai joins as VP of Technical Consulting, and Dr. Chang Lee joins as VP of APAC Consulting.

The new hires are now a part of PAREXEL’s Global Integrated Product Development and Compliance team and will be focused on helping clients deliver commercially viable, reimbursable products to market faster and more cost-effectively. All three have had experience working in various roles within or along with the FDA.

“We are always focused on building a robust team with global and diverse expertise,” said Dr. Paul Bridges, worldwide head of PAREXEL Consulting. “These new team members will contribute to our mission of helping clients take their products through development swiftly, successfully, and profitably, and ultimately, to the patients who need them most.”